摘要:
Hydroxamic acids having the formula are useful in treating disease conditions mediated by TNF-&agr;, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.
摘要:
Compounds of the formula: are useful in treating disease conditions mediated by TNF-&agr;, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.
摘要:
Methods and apparatus for the catalytic oxidation treatment of waste gas streams that contain entrained solids and gaseous air pollutants such as volatile organic compounds and carbon monoxide, and particularly methods and apparatus suitable for treating waste gas streams from wood burning processes. The method includes a step of washing the gas stream with water prior to the 5catalytic oxidation treatment.
摘要:
A system for the abatement of industrial process gases utilizes a rotary regenerative oxidizer comprised of one or more heat exchange beds, each bed comprised of a parallel, axial, and longitudinal array of heat regenerative channels that thermally and/or catalytically oxidize contaminated gases. Utilizing a rotary regenerative oxidizer, and if desired, a plurality of heat regenerative beds incorporated therein, facilitates the use of regenerative technology at lower gas flow rates, increases thermal efficiency, and significantly reduces the floor space normally required when implementing fixed-bed nonrotary regenerative oxidizers. The heat exchange channels may be catalytically treated to enhance oxidation of the pollutants at a lower temperature.
摘要:
A zeolite catalyst composition is provided in which a first or upstream zone of the catalyst has a lower metal (e.g., iron or copper) promoter loading than the metal promoter loading of the second or downstream zone of the catalyst. The first zone may contain from none up to about 1 percent by weight of the promoter and the second zone may contain from about 1 to 30 percent by weight promoter. The zeolite may be any suitable zeolite, especially one having a silica-to-alumina ratio of about 10 or more, and a kinetic pore size of about 7 to about 8 Angstroms with such pores being interconnected in all three crystallographic dimensions. The method of the invention provides for passing a gaseous stream containing oxygen, nitrogen oxides and ammonia sequentially through first and second catalysts as described above, the first catalyst favoring reduction of nitrogen oxides and the second catalyst favoring the oxidation or other decomposition of excess ammonia.
摘要:
Prior to upgrading a viscous feed by visbreaking, at least a portion of the feed is treated to remove a heavy phase in specified amounts, whereby the severity of the visbreaking may be increased. The Shell Hot Filtration number of the visbreaking product is reduced by at least 75%, compared to visbreaking of untreated feed at some severity.
摘要:
Sub-bituminous coal is directly liquefied in two stages by use of a liquefaction solvent containing insoluble material as well as 850.degree. F.+ material and 850.degree. F.- material derived from the second stage, and controlled temperature and conversion in the second stage. The process is in hydrogen balance.
摘要:
This invention relates to the preparation of fine particles of reactive beta-dicalcium silicate by means of a solid state process which comprises firing a mixture of calcium sulfate, silica and a reducing additive selected from the group consisting of calcium sulfide, carbon, carbon monoxide, methane and hydrogen, at a temperature of about 850.degree.-1000.degree. C. A carrier gas such as nitrogen or carbon dioxide may also be added, if desired. A high concentration of sulfur dioxide is a by-product of this process.
摘要:
A compound of Formula I, Formula II, Formula III, or Formula IV: or a pharmaceutically acceptable salt, solvate, and/or ester thereof, therapeutic compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
摘要:
The invention is related to compounds of Formula I: or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.